Prophase labs examines strategic opportunities to leverage its dtc multi-media infrastructure with telehealth physician networks for prescription drugs

Company announces ongoing strategic cost cutting to focus resources on new dtc marketing initiatives to drive growth and profitability dispels rumors of an investment bank initiating a capital raise garden city, ny, feb. 25, 2025 (globe newswire) -- prophase labs, inc. (nasdaq: prph) ("prophase" or the "company"), a next-generation biotech, genomics, and consumer products company provides a company update and schedules a conference call for later today. following the hiring of stu hollenshead, several new strategic opportunities have emerged for the company to capitalize on its dtc multi-media expertise and infrastructure.
PRPH Ratings Summary
PRPH Quant Ranking